Affinity Asset Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.8M	Buy	55,000 +23,869	+77%	+$11.4M	1.69%	22
2025 Q4	$18.1M	Sell	31,131 -83,869	-73%	-$42.8M	1.3%	33
2025 Q3	$52.7M	Buy	115,000 +35,000	+44%	+$13.1M	4.91%	5
2025 Q2	$24.2M	Hold	80,000	–	–	3.58%	10
2025 Q1	$26.5M	Sell	80,000 -2,500	-3%	-$821K	4.15%	10
2024 Q4	$25.5M	Sell	82,500 -17,500	-18%	-$4.92M	3.98%	8
2024 Q3	$21.2M	Sell	100,000 -10,000	-9%	-$2.56M	3.29%	8
2024 Q2	$30.8M	Sell	110,000 -5,000	-4%	-$1.19M	4.85%	4
2024 Q1	$30.7M	Buy	115,000 +15,000	+15%	+$3.53M	4.99%	5
2023 Q4	$23.1M	Buy	100,000 +15,000	+18%	+$2.62M	4.61%	4
2023 Q3	$12.4M	Sell	85,000 -7,500	-8%	-$1.41M	4.06%	8
2023 Q2	$21.4M	Sell	92,500 -500	-0.5%	-$135K	8.41%	1
2023 Q1	$22.5M	Buy	93,000 +23,000	+33%	+$6.27M	8.66%	2
2022 Q4	$20.3M	Sell	70,000 -30,000	-30%	-$2.93M	9.31%	2
2022 Q3	$6.5M	Hold	100,000	–	–	3%	15
2022 Q2	$7.16M	Buy	100,000 +25,000	+33%	+$1.84M	3.92%	11
2022 Q1	$7.36M	Buy	75,000 +10,000	+15%	+$843K	2.92%	14
2021 Q4	$5.51M	Buy	+65,000	New	+$5.34M	2.35%	21
2021 Q1	–	Sell	-5,000	Closed	-$556K	–	80
2020 Q4	$556K	Buy	+5,000	New	+$611K	0.34%	57